2 active shortage notices · 1 country. Rosuvastatin-Hemicalcium has 2 active shortage notices across 1 country (Germany). Information last verified by Mederti on 10 Nov 2026, based on notices published by BfArM.
Yes. As of the latest regulator updates, Rosuvastatin-Hemicalcium has 2 active shortage notices across 1 country (Germany). Status is refreshed daily from official regulatory sources.
Regulators attribute the current Rosuvastatin-Hemicalcium shortages to causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
Regulator-estimated resolution dates currently range from 31 Dec 2026 to 31 Jul 2027, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountMederti is an independent information service that aggregates notices published by official national medicines regulators, checked daily. It is not a regulator and is not affiliated with or endorsed by any regulator. A regulator's shortage status does not confirm or rule out commercial stock at any pharmacy or wholesaler. This page is not clinical advice; check the official notice and consult a pharmacist or prescriber before changing treatment.